HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus
Authors:
- M. El ChaarMCM. El Chaar
- J. TempleJTJ. Temple
- M. ThomasMTM. Thomas
- D. SpillaneDSD. Spillane
- D. CandottiDCD. Candotti
- J.P. AllainJAJ.P. Allain
Open Access
- 1 October 2010
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 53 (4) , 780-787
Abstract
No abstract availableKeywords
Funding Information
- National Health Service Blood and Transplant (BS2003/02)
- Bio-Rad
This publication has 29 references indexed in Scilit:
- Molecular characterization of occult hepatitis B virus in genotype E-infected subjectsJournal of General Virology, 2008
- Seven hundred and fifty‐nine (759) chances to learn: a 3‐year pilot project to analyse transfusion‐related near‐miss events in the Republic of IrelandVox Sanguinis, 2007
- Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignanciesBritish Journal of Haematology, 2007
- Hepatitis B genotype and YMDD profiles in an untreated Irish populationJournal of Clinical Virology, 2006
- Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virusInternal Medicine Journal, 2005
- Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive ImmunoprophylaxisHepatology, 2003
- REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1998
- Review of Counselling in a Transfusion Service: The London (UK) ExperienceVox Sanguinis, 1998
- De novo and apparent de novo hepatitis B virus infection after liver transplantationJournal of Hepatology, 1997
- Molecular Characterization Of Envelope Antigenic Variants Of Hepatitis B Virus From SpainThe Journal of Infectious Diseases, 1994